Sinovac Biotech Ltd. (NASDAQ:SVA)

motleyeddie (< 20) Submitted: 12/7/2006 4:30:16 PM : Start Price: $3.05 SVA Score: -41.34

china biotech stock...flu,hiv .....how many chinamen are there?

fibreoptik (89.06) Submitted: 11/29/2006 2:16:34 PM : Start Price: $3.18 SVA Score: -44.26

Profiteering on the backs of the unfortunate members of the ever-swelling People's Republic of China? Sounds lovely, where do I sign up? :p

Onestroke (21.23) Submitted: 11/28/2006 12:26:50 PM : Start Price: $2.81 SVA Score: -38.19

I'm intrigued by Chinese companies with a potential growth story. This one fits the bill.

bigmoneybastard (64.93) Submitted: 11/22/2006 11:59:52 PM : Start Price: $2.69 SVA Score: -34.18

good entry point

wmhammer (27.69) Submitted: 11/14/2006 10:48:29 AM : Start Price: $3.22 SVA Score: -46.26

Company has many new drugs in the pipe line, flu season is upon us, with olympics coming up in 2 yrs china, china will want to make sure people don't have to fear the bird flu

5STARsmallCAPS (78.15) Submitted: 11/4/2006 12:44:02 PM : Start Price: $3.19 SVA Score: -46.88

5-star $123 million market cap on 11/4/06
Chinese biotech: vaccines
5STARsmallCAPS picks five star stocks with the smallest market caps.

expdxer (< 20) Submitted: 10/27/2006 2:33:50 AM : Start Price: $3.25 SVA Score: -46.71

have great technology to combat dreaded viruses, especially bird flu. As their marketing gets more sophisticated they will be a more recognizable profitable company

goldenfool47 (< 20) Submitted: 10/16/2006 1:28:33 AM : Start Price: $3.34 SVA Score: -49.72

Flu season approaching

bfurbush (67.98) Submitted: 10/8/2006 8:05:36 PM : Start Price: $3.00 SVA Score: -44.97

Speculative company with a good cash position and expanding growth in the avian flu market. China has a huge market share which should only get larger. Best bet for the bird flu vaccine.

tponty (69.57) Submitted: 9/27/2006 9:48:56 PM : Start Price: $2.74 SVA Score: -41.84

Positive results from an early-stage trial of its experimental avian-flu vaccine. Also, developes affordable vaccines to the masses. The market in China alone is huge, then add in the populations of other developing nations...and, you have a huge clientel.